Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data

被引：0
|
作者：
Hamedi, Zahra
Lo, Andrea Yachee
Berkman, Jonathan David
Alesi, Erin R.
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Div Hematol Oncol & Palliat Care, Massey Comprehens Canc Ctr, Richmond, VA USA
[2] Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Richmond, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6022
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre's Real-World Experience
    Du, Yue
    Fu, Rui
    Levinsky, Justin T.
    Kamalraj, Pabiththa
    Chan, Kelvin K. W.
    Parmar, Ambica
    Eskander, Antoine
    Smoragiewicz, Martin
    CURRENT ONCOLOGY, 2023, 30 (10) : 8928 - 8935
  • [42] Pembrolizumab for cisplatin-failure recurrent/metastatic head and neck squamous cell carcinoma
    Chen, W-C.
    Chang, P. M-H.
    Lee, Y-T.
    Lu, W-B.
    Yang, M-H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Real-world outcomes for patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with nivolumab: A Galician multicentric study (Spain).
    Iglesias Rey, Leticia
    Vilchez Simo, Rocio
    Aguin Losada, Santiago
    Garcia Arroyo, Francisco Ramon
    Pena, Carolina
    Carral Maseda, Alberto
    Huidobro Vence, Gerardo
    Molina Diaz, Aurea
    Garcia-Gomez, Jesus
    Covela Rua, Marta
    Costa Rivas, Marinha
    Medina, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients
    Sukari, Ammar
    Nagasaka, Misako
    Diab, Maria
    Al Sibai, Khaled
    Atassi, Bassel
    Elayoubi, Jailan A.
    Kim, Seongho
    Kucuk, Omer
    CLINICAL OTOLARYNGOLOGY, 2019, 44 (04) : 639 - 643
  • [45] Cetuximab (C) and bevacizumab (B) in patients with recurrent or metastatic head and neck squamous cell carcinoma (SCCHN): An interim analysis
    Kies, M. S.
    Gibson, M. K.
    Kim, S. W.
    Savvides, P.
    Blumenschein, G. R., Jr.
    Worden, F.
    Chen, H.
    Grandis, J. R.
    Argiris, A. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
    Rubio-Casadevall, Jordi
    Cirauqui, Beatriz Cirauqui
    Trufero, Javier Martinez
    Serrahima, Maria Plana
    Castano, Almudena Garcia
    Maseda, Alberto Carral
    Docampo, Lara Iglesias
    Segura, Pedro Perez
    Lenza, Isaac Ceballos
    Calderon, Vanesa Gutierrez
    Salva, Jose Fuster
    Alvarez, Carolina Pena
    Hernandez, Irene
    del Barco Morillo, Edel
    Conde, Manuel Chaves
    Galan, Joaquina Martinez
    Sanchez, Marisa Duran
    Quiroga, Vanesa
    Ortega, Eugenia
    Mesia, Ricard
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] Real-world use of first-line pembrolizumab plus platinum plus taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinoma
    Black, Christopher M.
    Zheng, Dandan
    Hair, Gleicy M.
    Ai, Lei
    Wang, Liya
    Goto, Daisuke
    Lerman, Nati
    Bidadi, Behzad
    Hanna, Glenn J.
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma
    Hori, Ryusuke
    Shinohara, Shogo
    Kojima, Tsuyoshi
    Kagoshima, Hiroki
    Kitamura, Morimasa
    Tateya, Ichiro
    Tamaki, Hisanobu
    Kumabe, Yohei
    Asato, Ryo
    Harada, Hiroyuki
    Kitani, Yoshiharu
    Tsujimura, Takashi
    Honda, Keigo
    Ichimaru, Kazuyuki
    Omori, Koichi
    CANCERS, 2019, 11 (09)
  • [49] Real-world time on treatment analysis of pembrolizumab treated recurrent/metastatic head & neck squamous cell carcinoma (R/M HNSCC) patients stratified by ECOG PS in the United States.
    Black, Christopher Matthew
    Wang, Liya
    Ramakrishnan, Karthik
    Turzhitsky, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18007 - E18007
  • [50] Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
    Argiris, A.
    Kotsakis, A. P.
    Hoang, T.
    Worden, F. P.
    Savvides, P.
    Gibson, M. K.
    Gyanchandani, R.
    Blumenschein, G. R., Jr.
    Chen, H. X.
    Grandis, J. R.
    Harari, P. M.
    Kies, M. S.
    Kim, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 220 - 225
12345